Pharmaconex Cairo 2024: Egypt Pharmaceutical Industry Expo

Pharmaconex : Event Name: 
Category: Medical and Pharmaceuticals
Event Date: 08 – 10 September, 2024
Frequency: Annual
Location: Egypt International Exhibition Center – 2 El-Nasr Rd, Al Estad, Qesm Than Madinet Nasr, Cairo 4436001 Egypt
Organizer: Informa Markets – 7H Building, 4th Floor, Street 263 New Maadi, Cairo, Egypt
E-mail: pharmaconex[at]informa.com
Phone: +20 (0)10 2444 5031
Timing: 10:00 AM – 18:00 PM
Tickets: Visitor Registration Required – Click Here!

11th edition – Pharmaconex 2024 is Africa’s pharmaceutical manufacturing hub, connecting the entire supply chain in Egypt, the largest producer of the pharmaceutical market in the MENA region. Offering a comprehensive experience for the pharma community to network and build knowledge around the latest industry trends.

Pharmaconex 2024: About

Pharmaconex is Africa’s pharmaceutical hub connecting the entire pharmaceutical value chain for three days of unmissable business opportunities.

Incorporating 7500+ m² of exhibition space alongside a comprehensive conference agenda, the show is the perfect platform for global pharmaceutical companies to showcase their latest products, services, and technologies to an international audience of industry professionals.

The exhibition will host more than 200 international companies from across the world with over 4000 visitors

Visit Pharmaconex 2024:

Pharmaconex 2024 is ready to gather the pharmaceutical industry once again! Having attracted over 4,000 professional visitors from 20 countries in 2021, Pharmaconex continues to be Africa’s Pharmaceutical Hub, offering you unlimited opportunities to grow your network, make new business connections and find new suppliers.

Exhibition Sectors:

Uniting the global pharmaceutical industry through EIGHT dedicated product sectors with a combined mega show:

Pharmaceutical Industry Outlook:

Pharmaceutical Industry in the MENA region:

The MENA region is rapidly developing and extremely diverse, spanning both countries at the cutting-edge of innovation and technology as well as emerging economies. According to Trade Arabia, the territory’s pharmaceutical market stands to grow to USD 60 billion by 2025 driven by significant growth in the UAE as well as in North African giants Egypt and Algeria.

Pharmaceutical Industry in Egypt:

Egypt’s pharmaceutical market is among the most attractive in the MENA region. With the reforming economic and regulatory environment, there has been an increase in interest and investment from multinational pharmaceutical companies to enter this market. Egypt’s healthcare market is set for a period of transformation as Egypt is attempting to achieve universal healthcare access through the implementation of a comprehensive health insurance system.

Who will attend?

Why visit Pharmaconex 2024?

Overview about the North African pharmaceutical market:

The North African pharmaceutical market was valued at USD 12.98 Bn in 2018 and is expected to grow at a CAGR of 8% to reach to about USD 22.23 Bn by 2025. The growth of the pharmaceutical market in this region is driven by a number of demographic factors like rapidly changing population dynamics, where populations are expanding, but also ageing. Additionally, lifestyle changes have led to higher incidences of non-contagious chronic diseases and conditions – most notably cardiovascular diseases, obesity, cancer and type-2 diabetes.

Countries in North Africa that have managed to establish pharmaceutical manufacturing industries in recent years include Morocco, Tunisia and Algeria. In 2017, the industry in Morocco was able to cater to about 65% of the demand in the country (compared to 49% in Tunisia and 30% in Algeria). Pharmaceuticals produced in Morocco were also exported to Europe, other parts of Africa, and the Middle East. These capabilities could lead to partnerships being made between foreign and North African firms that have strong manufacturing and distribution networks.

Egypt’s pharmaceutical market is among the most attractive in the MENA region. With the reforming economic and regulatory environment, there has been an increase in interest and investment from multinational pharmaceutical companies to enter this market. Egypt’s healthcare market is set for a period of transformation as Egypt is attempting to achieve universal healthcare access through the implementation of a comprehensive health insurance system.

Egypt has a strong manufacturing industry; it is the largest producer of pharmaceuticals in the MENA region with around 90% of the drugs consumed in the country being manufactured locally with a much greater market share for generics.

The pharmaceutical market in Egypt was valued at USD 3.1 Bn in 2018 and is estimated to grow at a CAGR of around 8% to reach to about USD 5.2 Bn by 2025. The growth in the Egyptian market will be driven by the country’s growing demand for prescription medicines, a rapid increase in the country’s population and growing health awareness. In addition, the market is also expected to receive a boost from the initiatives taken up by the MoH to improve the regulatory environment as well as the implementation of the comprehensive health insurance system. However, disputes over medicine pricing, impact of high inflation and the lasting negative currency effects will continue to act as bottlenecks to the growth of this market.

Why Exhibit at Pharmaconex 2024?

Exhibiting at Pharmaconex will enable you to reach out to the region’s most influential and key decision-making professionals within the Middle East and North Africa. Get in front of thousands of owners, wholesalers, buyers and distributors in a dedicated trade environment, and build your business on scale, with guaranteed ROI.